{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:12:30Z","timestamp":1778533950880,"version":"3.51.4"},"publisher-location":"Cham","reference-count":60,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032186072","type":"print"},{"value":"9783032186089","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-18608-9_16","type":"book-chapter","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:35:51Z","timestamp":1778520951000},"page":"269-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pineal Tumors and Pineal Region Tumors"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-924X","authenticated-orcid":false,"given":"Ronan","family":"Tanguy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153646","volume":"14","author":"G Lombardi","year":"2022","unstructured":"Lombardi G, Poliani PL, Manara R, Berhouma M, Minniti G, Tabouret E, Razis E, Cerretti G, Zagonel V, Weller M, et al. Diagnosis and treatment of pineal region tumors in adults: a EURACAN overview. Cancer. 2022;14:3646. https:\/\/doi.org\/10.3390\/cancers14153646.","journal-title":"Cancer"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.15386\/mpr-1235","volume":"92","author":"BA Gheban","year":"2019","unstructured":"Gheban BA, Rosca IA, Crisan M. The morphological and functional characteristics of the pineal gland. Med Pharm Rep. 2019;92:226\u201334.","journal-title":"Med Pharm Rep"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuchi.2014.02.006","volume":"61","author":"C Mottolese","year":"2015","unstructured":"Mottolese C, Beuriat PA, Szathmari A. Pineal tumours: experience of the French National Register and the Lyon School, results and considerations. Neurochirurgie. 2015;61:223\u201335.","journal-title":"Neurochirurgie"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11060-010-0189-6","volume":"100","author":"AJ Clark","year":"2010","unstructured":"Clark AJ, Sughrue ME, Ivan ME, et al. Factors influencing overall survival rates for patients with pineocytoma. J Neurooncol. 2010;100:255\u201360.","journal-title":"J Neurooncol"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3171\/2012.5.JNS1251","volume":"117","author":"DA Wilson","year":"2012","unstructured":"Wilson DA, Awad AW, Brachman D, et al. Long-term radiosurgical control of subtotally resected adult pineocytomas. J Neurosurg. 2012;117:212\u20137.","journal-title":"J Neurosurg"},{"key":"16_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-5-122","volume":"5","author":"EM Stoiber","year":"2010","unstructured":"Stoiber EM, Schaible B, Herfarth K, et al. Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003\u2013a single institution\u2019s experience. Radiat Oncol. 2010;5:122. https:\/\/doi.org\/10.1186\/1748-717X-5-122.","journal-title":"Radiat Oncol"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3171\/2009.12.JNS091683","volume":"113","author":"AJ Clark","year":"2010","unstructured":"Clark AJ, Ivan ME, Sughrue ME, et al. Tumor control after surgery and radiotherapy for pineocytoma. J Neurosurg. 2010;113:319\u201324.","journal-title":"J Neurosurg"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1750-3639.2000.tb00242.x","volume":"10","author":"A Jouvet","year":"2000","unstructured":"Jouvet A, Saint-Pierre G, Fauchon F, et al. Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases. Brain Pathol. 2000;10:49\u201360.","journal-title":"Brain Pathol"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11060-021-03863-y","volume":"155","author":"VM Lu","year":"2021","unstructured":"Lu VM, Luther EM, Eichberg DG, Shah AH, Komotar RJ, Ivan ME. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade. J Neurooncol. 2021;155:165\u201372.","journal-title":"J Neurooncol"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.radonc.2016.10.025","volume":"121","author":"S Mallick","year":"2016","unstructured":"Mallick S, Benson R, Rath GK. Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis. Radiother Oncol. 2016;121:204\u20138.","journal-title":"Radiother Oncol"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/jnnp-2014-309805","volume":"87","author":"T Yu","year":"2016","unstructured":"Yu T, Sun X, Wang J, Ren X, Lin N, Lin S. Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosis. J Neurol Neurosurg Psychiatry. 2016;87:386\u201395.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"16_CR13","first-page":"1","volume":"15","author":"C Liu","year":"2023","unstructured":"Liu C, Carmicheal J, Baine MJ, Zhang C. Radiation therapy for pineal parenchymal tumor of intermediate differentiation: a case series and literature review. J CNS Dis. 2023;15:1\u20139.","journal-title":"J CNS Dis"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1440-1789.2006.00657.x","volume":"26","author":"M Pusztaszeri","year":"2006","unstructured":"Pusztaszeri M, Pica A, Janzer R. Pineal parenchymal tumors of intermediate differentiation in adults: case report and literature review. Neuropathology. 2006;26:153\u20137.","journal-title":"Neuropathology"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/neuonc\/now105","volume":"19","author":"DR Raleigh","year":"2017","unstructured":"Raleigh DR, Solomon DA, Lloyd SA, Lazar A, Garcia MA, Sneed PK, et al. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro Oncol. 2017;19:78\u201388.","journal-title":"Neuro Oncol"},{"issue":"1","key":"16_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/neuros\/nyx005","volume":"81","author":"KA Parikh","year":"2017","unstructured":"Parikh KA, Venable GT, Orr BA, et al. Pineoblastoma\u2014the experience at St. Jude Children\u2019s Research Hospital. Neurosurgery. 2017;81(1):120\u20138.","journal-title":"Neurosurgery"},{"issue":"4","key":"16_CR17","first-page":"576","volume":"19","author":"M Mynarek","year":"2017","unstructured":"Mynarek M, Pizer B, Dufour C, et al. Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data. Neuro Oncol. 2017;19(4):576\u201385.","journal-title":"Neuro Oncol"},{"issue":"2","key":"16_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-019-02106-9","volume":"139","author":"APY Liu","year":"2020","unstructured":"Liu APY, Gudenas B, Lin T, et al. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. 2020;139(2):259\u201371.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"16_CR19","volume":"4","author":"JR Hansford","year":"2022","unstructured":"Hansford JR, Jie H, Raelene E, et al. Pediatric pineoblastoma: a pooled outcome study of North American and Australian therapeutic data. Neurooncol Adv. 2022;4(1):vdac056.","journal-title":"Neurooncol Adv"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1200\/JCO.1995.13.7.1687","volume":"13","author":"BH Cohen","year":"1995","unstructured":"Cohen BH, Zeltzer PM, Boyett JM, et al. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Children\u2019s Cancer Group randomized trial. J Clin Oncol. 1995;13:1687\u201396.","journal-title":"J Clin Oncol"},{"key":"16_CR21","doi-asserted-by":"crossref","unstructured":"Hwang EI, Kool M, Burger PC, et al. Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the Children\u2019s Oncology Group Randomized ACNS0332 Trial. J Clin Oncol. 2018:JCO2017764720.","DOI":"10.1200\/JCO.2017.76.4720"},{"issue":"2","key":"16_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11060-006-9221-2","volume":"81","author":"BG Hinkes","year":"2007","unstructured":"Hinkes BG, von Hoff K, Deinlein F, et al. Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91. J Neurooncol. 2007;81(2):217\u201323.","journal-title":"J Neurooncol"},{"issue":"2","key":"16_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/pbc.21307","volume":"50","author":"J Fangusaro","year":"2008","unstructured":"Fangusaro J, Finlay J, Sposto R, et al. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatr Blood Cancer. 2008;50(2):312\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"16_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/neuonc\/nos292","volume":"15","author":"C Friedrich","year":"2013","unstructured":"Friedrich C, von Bueren AO, von Hoff K, et al. Treatment of young children with CNS-primitive neuroectodermal tumors\/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol. 2013;15(2):224\u201334.","journal-title":"Neuro Oncol"},{"issue":"5","key":"16_CR25","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.25405","volume":"62","author":"RI Jakacki","year":"2015","unstructured":"Jakacki RI, Burger PC, Kocak M, et al. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2015;62(5):776\u201383.","journal-title":"Pediatr Blood Cancer"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","volume":"17","author":"PM Zeltzer","year":"1999","unstructured":"Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children\u2019s Cancer Group 921 Randomized Phase III Study. J Clin Oncol. 1999;17:832\u201345.","journal-title":"J Clin Oncol"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fonc.2020.01021","volume":"10","author":"Y Jing","year":"2020","unstructured":"Jing Y, Deng W, Zhang H, Jiang Y, Dong Z, Fan F, Sun P. Development and validation of a prognostic nomogram to predict cancer-specific survival in adult patients with pineoblastoma. Front Oncol. 2020;10:1021.","journal-title":"Front Oncol"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11060-009-9931-3","volume":"95","author":"A Cerase","year":"2009","unstructured":"Cerase A, Vallone IM, Di Pietro G, Oliveri G, Miracco C, Venturi C. Neuroradiological follow-up of the growth of papillary tumor of the pineal region: a case report. J Neurooncol. 2009;95:433\u20135.","journal-title":"J Neurooncol"},{"issue":"3","key":"16_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1750-3639.2008.00128.x","volume":"18","author":"M F\u00e8vre-Montange","year":"2008","unstructured":"F\u00e8vre-Montange M, Szathmari A, Champier J, et al. Pineocytoma and pineal parenchymal tumors of intermediate differentiation presenting cytologic pleomorphism: a multicenter study. Brain Pathol. 2008;18(3):354\u20139. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00128.x. Epub 2008 Mar 26.","journal-title":"Brain Pathol"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1227\/01.NEU.0000255443.44365.77","volume":"60","author":"E Dagnew","year":"2007","unstructured":"Dagnew E, Langford L, Lang F, DeMonte F. Papillary tumors of the pineal region: case report. Neurosurgery. 2007;60:953\u20135.","journal-title":"Neurosurgery"},{"key":"16_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2019.105646","volume":"190","author":"Andrea Lancia","year":"2020","unstructured":"Andrea Lancia, Carlotta Becherini, Beatrice Detti, et al. Radiotherapy for papillary tumor of the pineal region: a systematic review of the literature. Clin Neurol Neurosurg. 2020;190:105646.","journal-title":"Clin Neurol Neurosurg"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/02688690701583794","volume":"22","author":"T Santarius","year":"2008","unstructured":"Santarius T, Joseph JA, Tsang KT, O\u2019Donovan DG, Kirollos RW. Papillary tumour of the pinal region. Br J Neurosurg. 2008;22:116\u2013220.","journal-title":"Br J Neurosurg"},{"key":"16_CR33","volume-title":"Intracranial and spinal radiotherapy, practical guides in radiation oncology","author":"C-L Tseng","year":"2021","unstructured":"Tseng C-L, Sahgal A. In: Halasz LM, et al., editors. Intracranial and spinal radiotherapy, practical guides in radiation oncology. Springer; 2021."},{"issue":"2","key":"16_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11060-013-1050-5","volume":"112","author":"F Fauchon","year":"2013","unstructured":"Fauchon F, Hasselblatt M, Jouvet A, et al. Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region: a multicenter study. J Neurooncol. 2013;112(2):223\u201331.","journal-title":"J Neurooncol"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00401-019-02094-w","volume":"139","author":"C Thomas","year":"2020","unstructured":"Thomas C, Wefers A, Bens S, Nemes K, Agaimy A, Oyen F, Vogelgesang S, Rodriguez FJ, Brett FM, McLendon R, et al. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults. Acta Neuropathol. 2020;139:277\u201386.","journal-title":"Acta Neuropathol"},{"issue":"suppl_5","key":"16_CR36","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014. Neuro Oncol. 2017;19(suppl_5):v1\u2013v88.","journal-title":"Neuro Oncol"},{"issue":"Suppl","key":"16_CR37","first-page":"i","volume":"43","author":"Committee of Brain Tumor Registry of Japan","year":"2003","unstructured":"Committee of Brain Tumor Registry of Japan. Report of brain tumor registry of Japan (1969\u20131996). Neurol Med Chir (Tokyo). 2003;43(Suppl):i\u2013vii, 1\u2013111.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"4","key":"16_CR39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ijrobp.2011.04.033","volume":"82","author":"DC Weksberg","year":"2012","unstructured":"Weksberg DC, Shibamoto Y, Paulino AC. Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys. 2012;82(4):1341\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"16_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/MPH.0b013e3181983af5","volume":"31","author":"TL Goodwin","year":"2009","unstructured":"Goodwin TL, Sainani K, Fisher PG. Incidence patterns of central nervous system germ cell tumors: a SEER Study. J Pediatr Hematol Oncol. 2009;31(8):541\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"16_CR41","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/neuonc\/noab295","volume":"24","author":"KN Koh","year":"2022","unstructured":"Koh KN, Wong RX, Lee DE, et al. Outcomes of intracranial germinoma-a retrospective multinational Asian study on effect of clinical presentation and differential treatment strategies. Neuro Oncol. 2022;24(8):1389\u201399.","journal-title":"Neuro Oncol"},{"issue":"7","key":"16_CR42","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/pbc.24097","volume":"59","author":"J Allen","year":"2012","unstructured":"Allen J, Chacko J, Donahue B, et al. Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma. Pediatr Blood Cancer. 2012;59(7):1180\u20132.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"16_CR43","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S1470-2045(15)00244-2","volume":"16","author":"MJ Murray","year":"2015","unstructured":"Murray MJ, Bartels U, Nishikawa R, et al. Consensus on the management of intracranial germ-cell tumours. Lancet Oncol. 2015;16(9):e470\u20137.","journal-title":"Lancet Oncol"},{"issue":"6","key":"16_CR44","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/neuonc\/not019","volume":"15","author":"G Calaminus","year":"2013","unstructured":"Calaminus G, Kortmann R, Worch J, et al. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol. 2013;15(6):788\u201396.","journal-title":"Neuro Oncol"},{"issue":"1","key":"16_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.radonc.2008.10.012","volume":"91","author":"J Cho","year":"2009","unstructured":"Cho J, Choi JU, Kim DS, et al. Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma. Radiother Oncol. 2009;91(1):75\u20139.","journal-title":"Radiother Oncol"},{"issue":"10","key":"16_CR46","first-page":"5715","volume":"34","author":"JH Joo","year":"2014","unstructured":"Joo JH, Park JH, Ra YS, et al. Treatment outcome of radiation therapy for intracranial germinoma: adaptive radiation field in relation to response to chemotherapy. Anticancer Res. 2014;34(10):5715\u201321.","journal-title":"Anticancer Res"},{"issue":"7","key":"16_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1470-2045(05)70245-X","volume":"6","author":"SJ Rogers","year":"2005","unstructured":"Rogers SJ, Mosleh-Shirazi MA, Saran FH. Radiotherapy of localised intra-cranial germinoma: time to sever historical ties? Lancet Oncol. 2005;6(7):509\u201319.","journal-title":"Lancet Oncol"},{"issue":"3","key":"16_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/pbc.20815","volume":"48","author":"C Kretschmar","year":"2007","unstructured":"Kretschmar C, Kleinberg L, Greenberg M, et al. Pre-radiation chemo-therapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2007;48(3):285\u201391.","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"16_CR49","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1200\/JCO.1996.14.11.2908","volume":"14","author":"C Balmaceda","year":"1996","unstructured":"Balmaceda C, Heller G, Rosenblum M, et al. Chemotherapy without irradiation\u2013a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol. 1996;14(11):2908\u201315.","journal-title":"J Clin Oncol"},{"issue":"10","key":"16_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29172","volume":"68","author":"RT Graham","year":"2021","unstructured":"Graham RT, Abu-Arja MH, Stanek JR, et al. Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. Pediatr Blood Cancer. 2021;68(10):e29172.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"16_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1023\/A:1005732105727","volume":"32","author":"PL Robertson","year":"1997","unstructured":"Robertson PL, DaRosso RC, Allen JC. Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neurooncol. 1997;32(1):71\u201380.","journal-title":"J Neurooncol"},{"issue":"22","key":"16_CR52","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1200\/JCO.2014.59.5132","volume":"33","author":"S Goldman","year":"2015","unstructured":"Goldman S, Bouffet E, Fisher PG, et al. Phase II trial assessing the ability of neoadjuvant chemotherapy with or without second-look surgery to eliminate measurable disease for nongerminomatous germ cell tumors: a Children\u2019s Oncology Group Study. J Clin Oncol. 2015;33(22):2464\u201371.","journal-title":"J Clin Oncol"},{"issue":"3","key":"16_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-2004-822626","volume":"216","author":"G Calaminus","year":"2004","unstructured":"Calaminus G, Bamberg M, J\u00fcrgens H, et al. Impact of surgery, chemo-therapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr. 2004;216(3):141\u20139.","journal-title":"Klin Padiatr"},{"issue":"3","key":"16_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ijrobp.2011.12.077","volume":"84","author":"JW Kim","year":"2012","unstructured":"Kim JW, Kim WC, Cho JH, et al. A multimodal approach including cranio-spinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors. Int J Radiat Oncol Biol Phys. 2012;84(3):625\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"16_CR55","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/neuonc\/nox122","volume":"19","author":"G Calaminus","year":"2017","unstructured":"Calaminus G, Frappaz D, Kortmann RD, et al. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol. 2017;19(12):1661\u201372.","journal-title":"Neuro Oncol"},{"issue":"5","key":"16_CR56","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000257524","volume":"45","author":"X Huang","year":"2009","unstructured":"Huang X, Zhang R, Zhou LF. Diagnosis and treatment of intracranial immature teratoma. Pediatr Neurosurg. 2009;45(5):354\u201360.","journal-title":"Pediatr Neurosurg"},{"issue":"12","key":"16_CR57","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00381-009-0974-8","volume":"25","author":"YH Lee","year":"2009","unstructured":"Lee YH, Park EK, Park YS, et al. Treatment and outcomes of primary intracranial teratoma. Childs Nerv Syst. 2009;25(12):1581\u20137.","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"16_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/mpo.2950250109","volume":"25","author":"PK Duffner","year":"1995","unstructured":"Duffner PK, Cohen ME, Sanford RA, et al. Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology Group. Med Pediatr Oncol. 1995;25(1):38\u201344.","journal-title":"Med Pediatr Oncol"},{"issue":"24","key":"16_CR59","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199306173282401","volume":"328","author":"PK Duffner","year":"1993","unstructured":"Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993;328(24):1725\u201331.","journal-title":"N Engl J Med"},{"issue":"1","key":"16_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2015.03.019","volume":"53","author":"BH Cohen","year":"2015","unstructured":"Cohen BH, Geyer JR, Miller DC, et al. Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 phase I\/II study. A report from the Children\u2019s Oncology Group. Pediatr Neurol. 2015;53(1):31\u201346.","journal-title":"Pediatr Neurol"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/pbc.26074","volume":"63","author":"KJ Nazemi","year":"2016","unstructured":"Nazemi KJ, Shen V, Finlay JL, Boyett J, Kocak M, Lafond D, Gardner SL, Packer RJ, Nicholson HS. High incidence of veno-occlusive disease with myeloablative chemotherapy following craniospinal irradiation in children with newly diagnosed high-risk CNS embryonal tumors: a report from the Children\u2019s Oncology Group (CCG-99702). Pediatr Blood Cancer. 2016;63:1563\u201370.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Advances and Technical Standards in Neurosurgery","Pineal Tumors and Pineal Region Tumors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-18608-9_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:02:48Z","timestamp":1778533368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-18608-9_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032186072","9783032186089"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-18608-9_16","relation":{},"ISSN":["0095-4829","1869-9189"],"issn-type":[{"value":"0095-4829","type":"print"},{"value":"1869-9189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"12 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}